Medifast Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Medifast, Inc. (MED) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income2.0999.42143.57164.03102.8677.9255.79
Depreciation & Amortization12.7113.1110.986.814.647.704.44
Deferred Income Tax-7.401.21-0.92-3.720.601.60-2.69
Stock Based Compensation7.368.1911.059.906.800.000.00
Change in Working Capital-9.7520.2821.65-87.6526.90-11.13-1.52
Change in Inventory12.1764.2761.19-126.65-4.620.000.00
Change in Accounts Payable-34.99-35.71-37.5954.3828.010.000.00
Change in Other Working Capital16.180.87-3.325.07-1.660.000.00
Other Operating Activities16.185.825.175.079.998.140.00
Net Cash from Operating Activities24.48147.66194.5794.55145.2084.2660.82
Investing Activities
Capital Expenditures-7.45-6.48-16.68-34.215.8910.06-4.74
Purchases of Investments-46.60-54.565.275.154.610.000.00
Sales/Maturities of Investments27.535.195.275.154.613.733.55
Other Investing Activities0.100.000.000.000.000.000.00
Net Cash from Investing Activities-26.52-61.05-11.41-29.06-1.28-6.33-1.20
Financing Activities
Common Stock Issued0.040.19-127.96-62.09-5.55-47.21-30.72
Common Stock Repurchased-0.84-6.96-127.96-62.09-5.550.000.00
Dividends Paid-0.72-73.02-71.62-63.8653.1935.40-23.16
Other Financing Activities0.040.000.000.000.000.000.00
Net Cash from Financing Activities-1.52-79.79-199.58-125.13-57.14-82.32-53.33
Summary
Effect of Forex Changes on Cash0.05-0.07-0.070.11-0.020.000.00
Net Change in Cash-3.566.75-16.49-59.6586.75-4.396.29
Cash at Beginning of Period94.4487.69104.18163.7276.9781.3675.08
Cash at End of Period90.9394.4487.69104.18163.7276.9781.36
Free Cash Flow17.02141.17177.8960.34139.3174.2055.88
Supplemental Disclosures
Income Taxes Paid-1.6234.2637.2156.7624.6417.3114.61